Welcome to our dedicated page for Addus HomeCare news (Ticker: $ADUS), a resource for investors and traders seeking the latest updates and insights on Addus HomeCare stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Addus HomeCare's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Addus HomeCare's position in the market.
Addus HomeCare (Nasdaq: ADUS) will participate in the BofA Securities Health Care Conference 2024 in Las Vegas, Nevada. The company's top executives will be present at the conference to showcase their services and engage with potential investors. A live broadcast and replay of the presentation will be available on the company's website for one month.
Addus HomeCare (NASDAQ: ADUS) announced its first quarter 2024 financial results, showing an 11.6% revenue growth to $280.7 million. Net income was $15.8 million, with adjusted net income per diluted share increasing to $1.21. Adjusted EBITDA rose by 24.6% to $32.4 million. The company is focused on strategic growth, investing in acquisitions, and maintaining a strong financial position.
